Ledger.Open graph →
SEC Form D · filed February 13, 2017

Gila Therapeutics, Inc

Offering
$500K
Sold
—
Exemption
Rule 506(c)
Industry
Biotechnology
Location
Minneapolis, MN
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (17)

Andres J. Acosta · Minneapolis, MNPromoterRichard J. Horan · Minneapolis, MNDirectorSergei J. Zolutukhin · Minneapolis, MNPromoterThomas J. Vasicek · Minneapolis, MNExec · Director · PromoterJon J. Freeman · Minneapolis, MNExecChristopher J. De Souza · Minneapolis, MNDirectorRobert K. Lewis · Austin, TXExec · Director · PromoterLarry Perdido · Austin, TXPromoterRaul C. Romero · Austin, TXPromoterRichard J. Horan · Minneapolis, MNDirectorDavid Mc Geough · Killiney, Dublin, IrelandExecGordon G. Repp · Chicago, ILDirectorDemetri G. Rackos · Chicago, ILExecJoseph K. Munoz · Chicago, ILPromoterRobert K. Hagan · Chicago, ILExec · Director · PromoterRobert B. Crumpton, Iii · Birmingham, ALPromoterChristopher J. De Souza · Minneapolis, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗